Myocardial Staining (TMPG 1) Post-Stent in AMI

10
Myocardial Staining (TMPG 1) Myocardial Staining (TMPG 1) Post-Stent Post-Stent in AMI in AMI 0 10 20 30 Pre-Stent Post-Stent p = 0.004 n = 118 n = 118 CM Gibson, J Thrombolysis & Thrombosis, 2002 in press 13.5% 28.6% % TMPG 1

description

Myocardial Staining (TMPG 1)  Post-Stent in AMI. p = 0.004. 28.6%. % TMPG 1. 13.5%. n = 118. n = 118. CM Gibson, J Thrombolysis & Thrombosis, 2002 in press. Intracoronary Devices and Embolic Potential. Topol, E. Circulation. 2000;101:570-580. - PowerPoint PPT Presentation

Transcript of Myocardial Staining (TMPG 1) Post-Stent in AMI

Page 1: Myocardial Staining (TMPG 1)   Post-Stent  in AMI

Myocardial Staining (TMPG 1) Myocardial Staining (TMPG 1) Post-Stent in AMI Post-Stent in AMIMyocardial Staining (TMPG 1) Myocardial Staining (TMPG 1) Post-Stent in AMI Post-Stent in AMI

0

10

20

30

Pre-Stent Post-Stent

0

10

20

30

Pre-Stent Post-Stent

p = 0.004p = 0.004

n = 118n = 118n = 118n = 118

CM Gibson, J Thrombolysis & Thrombosis, 2002 in pressCM Gibson, J Thrombolysis & Thrombosis, 2002 in press

13.5%13.5%

28.6%28.6%

% T

MP

G 1

% T

MP

G 1

Page 2: Myocardial Staining (TMPG 1)   Post-Stent  in AMI

Topol, E. Circulation. 2000;101:570-580. Topol, E. Circulation. 2000;101:570-580.

Intracoronary Devices and Intracoronary Devices and Embolic PotentialEmbolic Potential

Intracoronary Devices and Intracoronary Devices and Embolic PotentialEmbolic Potential

Page 3: Myocardial Staining (TMPG 1)   Post-Stent  in AMI

Intracoronary Serotonin Release After StentingIntracoronary Serotonin Release After Stenting

Leosco et al, AJC 1999;84:1317-1322 Leosco et al, AJC 1999;84:1317-1322

Stenting causes greater serotonin release than PTCA

Stenting may cause greater arterial damage, greater plt. deposition, and greater plt. activation leading to vasoconstriction

Stenting causes greater serotonin release than PTCA

Stenting may cause greater arterial damage, greater plt. deposition, and greater plt. activation leading to vasoconstriction

Page 4: Myocardial Staining (TMPG 1)   Post-Stent  in AMI

Impact of IC Adenosine & GP 2b3a Inhibitor on TIMI Myocardial Perfusion Grade

Impact of IC Adenosine & GP 2b3a Inhibitor on TIMI Myocardial Perfusion Grade

Post PTCAPost PTCA Post PTCA + AdenosinePost PTCA + Adenosine

DistalLAD with no blush

DistalLAD with no blush

DistalLAD with

TIMI 3 Grade Blush

DistalLAD with

TIMI 3 Grade Blush

(DSA = 0.1 Gray)(DSA = 0.1 Gray) (DSA = 5.2 Gray)(DSA = 5.2 Gray)

CM Gibson 2000CM Gibson 2000

Page 5: Myocardial Staining (TMPG 1)   Post-Stent  in AMI

Impact of IC Adenosine on Clinical & Electrocardiographic Impact of IC Adenosine on Clinical & Electrocardiographic Outcomes in the Setting Primary PTCAOutcomes in the Setting Primary PTCA

Impact of IC Adenosine on Clinical & Electrocardiographic Impact of IC Adenosine on Clinical & Electrocardiographic Outcomes in the Setting Primary PTCAOutcomes in the Setting Primary PTCA

18

00

20

40

60

80

100

Death

18

00

20

40

60

80

100

Death

85

59

0

20

40

60

80

10085

59

0

20

40

60

80

100

% Developing Q Waves

% Developing Q Waves

48

18

0

20

40

60

80

100

48

18

0

20

40

60

80

100

% Death, MI, CHF, Recurrent Angina% Death, MI, CHF, Recurrent Angina

p < 0.02p < 0.02 p < 0.04p < 0.04p < 0.03p < 0.03

Marzilli et al, Circulation 2000; 101:2154-2159Marzilli et al, Circulation 2000; 101:2154-2159

N=27N=27 PlaceboPlacebo N=27N=27 Adenosine 4 mg in 2 ml via central lumen of PTCA balloonAdenosine 4 mg in 2 ml via central lumen of PTCA balloon

% o

f P

atie

nts

% o

f P

atie

nts

Page 6: Myocardial Staining (TMPG 1)   Post-Stent  in AMI

Hypothermia in MI Reduces Infarct SizeHypothermia in MI Reduces Infarct SizeHypothermia in MI Reduces Infarct SizeHypothermia in MI Reduces Infarct Size

No CoolingNo Cooling CoolingCooling

Page 7: Myocardial Staining (TMPG 1)   Post-Stent  in AMI

Non-culprit CTFCs Improve Following PCI of the Culprit ArteryNon-culprit CTFCs Improve Following PCI of the Culprit ArteryNon-culprit CTFCs Improve Following PCI of the Culprit ArteryNon-culprit CTFCs Improve Following PCI of the Culprit Artery

-2

0

2

4

6

8

10

12

CTFC > 28 CTFC < 28-2

0

2

4

6

8

10

12

CTFC > 28 CTFC < 28

• Dilating the culprit stenosis speeds up flow in the uninvolved artery (non-culprit artery) in acute coronary syndromes

• Dilating the culprit stenosis speeds up flow in the uninvolved artery (non-culprit artery) in acute coronary syndromes

CT

FC

Im

pro

vem

en

t in

No

n-C

ulp

rit

CT

FC

Im

pro

vem

en

t in

No

n-C

ulp

rit

N = 134N = 134

N = 228N = 228

- 0.7 + 8.6- 0.7 + 8.6

10.4 + 16.010.4 + 16.0

P < 0.0001P < 0.0001

Gibson CM et al, Am J Cardiol 2000Gibson CM et al, Am J Cardiol 2000

Page 8: Myocardial Staining (TMPG 1)   Post-Stent  in AMI

Alpha Adrenergic Blockade Improves Recovery of Myocardial Perfusion After Stenting in AMI

Alpha Adrenergic Blockade Improves Recovery of Myocardial Perfusion After Stenting in AMI

Gregorini et al, Circulation 1999; 99: 482-490Gregorini et al, Circulation 1999; 99: 482-490

Page 9: Myocardial Staining (TMPG 1)   Post-Stent  in AMI

Alpha Adrenergic Blockade Improves Recovery of Myocardial Perfusion After Stenting in AMI

Alpha Adrenergic Blockade Improves Recovery of Myocardial Perfusion After Stenting in AMI

Gregorini et al, Circulation 1999; 99: 482-490Gregorini et al, Circulation 1999; 99: 482-490

Page 10: Myocardial Staining (TMPG 1)   Post-Stent  in AMI

Downstream TargetsDownstream TargetsDownstream TargetsDownstream Targets

• Large embolii: Filters• Small embolii (thrombii): Filters & GP 2b3a

inhibitors• Vasoconstrictor release: GP 2b3a inhibitors• Spasm: Adenosine, Ca channel blockers,

alpha blockers, avoid over sizing with PCI, high pressure inflations, serotonin inhibitors, endothelin inhibitors

• Endothelial & Myocardial swelling: Ca channel blockers, hypothermia, DHEA, Na / H pump inhibitors, anti-inflammatory approaches

• Large embolii: Filters• Small embolii (thrombii): Filters & GP 2b3a

inhibitors• Vasoconstrictor release: GP 2b3a inhibitors• Spasm: Adenosine, Ca channel blockers,

alpha blockers, avoid over sizing with PCI, high pressure inflations, serotonin inhibitors, endothelin inhibitors

• Endothelial & Myocardial swelling: Ca channel blockers, hypothermia, DHEA, Na / H pump inhibitors, anti-inflammatory approaches